|
Sign In to gain access to subscriptions and/or personal tools.
|
The role of matrix metalloproteinases in vascular disease
IM Loftus
Department of Surgery, Leicester University, Leicester, UK, ianloftus{at}aol.com
MM Thompson
Department of Surgery, Leicester University, Leicester, UK
There is growing interest in the role of matrix metalloproteinasesin vascular diseases. These conditions are often characterized by excessive tissue remodelling, and increased matrix metalloproteinase activity has been demonstrated in aneurysms, intimal hyperplasia and atherosclerotic plaque disruption. These enzymes represent a potential target for therapeutic intervention to modify vascular pathology.
The core of this review is derived from a MEDLINE database literature search. The review found that there is convincing evidence of increased matrix metalloproteinase activity in a spectrum of vascular disease. Evidence for an imbalance promoting increased matrix degradation is less well documented. However, studies of matrix metalloproteinase inhibition in vascular disease models suggest potential therapeutic benefit.
In conclusion, in vivo studies of matrix metalloproteinase inhibition are required to further study the potential for reversal or deceleration of the excessive tissue remodelling that accompanies vascular disorders.
Key Words: aneurysm atherosclerosis intimal hyperplasia matrix metalloproteinase
Vascular Medicine, Vol. 7, No. 2,
117-133 (2002)
DOI: 10.1191/1358863x02vm420ra

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Z. Jiang, M. Tao, K. A. Omalley, D. Wang, C. K. Ozaki, and S. A. Berceli
Established neointimal hyperplasia in vein grafts expands via TGF-{beta}-mediated progressive fibrosis
Am J Physiol Heart Circ Physiol,
October 1, 2009;
297(4):
H1200 - H1207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Bown, P. S. Braund, J. Thompson, N. J.M. London, N. J. Samani, and R. D. Sayers
Association Between the Coronary Artery Disease Risk Locus on Chromosome 9p21.3 and Abdominal Aortic Aneurysm
Circ Cardiovasc Genet,
October 1, 2008;
1(1):
39 - 42.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Pico, J. Labreuche, D. Seilhean, C. Duyckaerts, J.-J. Hauw, and P. Amarenco
Association of Small-Vessel Disease With Dilatative Arteriopathy of the Brain: Neuropathologic Evidence
Stroke,
April 1, 2007;
38(4):
1197 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sangiorgi, A. Mauriello, E. Bonanno, C. Oxvig, C. A. Conover, M. Christiansen, S. Trimarchi, V. Rampoldi, D. R. Holmes Jr, R. S. Schwartz, et al.
Pregnancy-Associated Plasma Protein-A Is Markedly Expressed by Monocyte-Macrophage Cells in Vulnerable and Ruptured Carotid Atherosclerotic Plaques: A Link Between Inflammation and Cerebrovascular Events
J. Am. Coll. Cardiol.,
June 6, 2006;
47(11):
2201 - 2211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Schiller, A. S. Black, G. P. Bradshaw, D. J. Bonnet, and L. K. Curtiss
Participation of macrophages in atherosclerotic lesion morphology in LDLr-/- mice
J. Lipid Res.,
August 1, 2004;
45(8):
1398 - 1409.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|